Syntegra Private Wealth Group LLC Has $534,000 Stake in UnitedHealth Group Incorporated $UNH

Syntegra Private Wealth Group LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,711 shares of the healthcare conglomerate’s stock after purchasing an additional 127 shares during the period. Syntegra Private Wealth Group LLC’s holdings in UnitedHealth Group were worth $534,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Liberty One Investment Management LLC boosted its position in shares of UnitedHealth Group by 46.0% in the second quarter. Liberty One Investment Management LLC now owns 82,001 shares of the healthcare conglomerate’s stock valued at $25,582,000 after acquiring an additional 25,846 shares during the period. DekaBank Deutsche Girozentrale increased its position in shares of UnitedHealth Group by 1.1% in the second quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate’s stock worth $291,636,000 after purchasing an additional 10,633 shares during the period. Princeton Global Asset Management LLC raised its position in shares of UnitedHealth Group by 96.7% in the 2nd quarter. Princeton Global Asset Management LLC now owns 474 shares of the healthcare conglomerate’s stock valued at $148,000 after buying an additional 233 shares in the last quarter. Crewe Advisors LLC bought a new stake in UnitedHealth Group during the second quarter worth $214,000. Finally, Alan B Lancz & Associates Inc. acquired a new stake in UnitedHealth Group in the second quarter valued at about $407,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $364.31 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock’s fifty day simple moving average is $331.62 and its two-hundred day simple moving average is $341.12. The stock has a market cap of $329.95 billion, a PE ratio of 15.78, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on UNH. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Barclays lifted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Finally, Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.